Earnings estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
No. of analysts | 1 | 0 | 3 | 3 |
Avg. Estimate | 0.75 | 0 | 3.92 | 3.94 |
Low estimate | 0.75 | 0 | 3.88 | 3.77 |
High estimate | 0.75 | 0 | 3.95 | 4.1 |
Year ago EPS | 0.6 | 0.9 | 3.44 | 3.92 |
Revenue estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
No. of analysts | 2 | 1 | 3 | 3 |
Avg. Estimate | 9.54B | 8.94B | 37.13B | 38.99B |
Low estimate | 9.41B | 8.94B | 36.71B | 38.19B |
High estimate | 9.68B | 8.94B | 37.77B | 39.82B |
Year ago sales | 8.66B | 8.45B | 36.1B | 37.13B |
Sales growth (year/est) | 10.30% | 5.80% | 2.90% | 5.00% |
Earnings history | 30/12/2022 | 30/03/2023 | 29/06/2023 | 29/09/2023 |
---|---|---|---|---|
Est. EPS | 0.5 | 0.82 | 0.87 | 1.14 |
Actual EPS | 0.6 | 0.9 | 0.97 | 1.28 |
Difference | 0.1 | 0.08 | 0.1 | 0.14 |
Surprise % | 20.00% | 9.80% | 11.50% | 12.30% |
EPS trend | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
Current estimate | 0.75 | 0 | 3.92 | 3.94 |
7 days ago | 0.74 | 0 | 3.92 | 3.98 |
30 days ago | 0.71 | 0 | 3.89 | 3.86 |
60 days ago | 0.75 | 0 | 3.9 | 3.96 |
90 days ago | 0.75 | 0 | 3.81 | 3.96 |
EPS revisions | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
Up last 7 days | 1 | N/A | 1 | N/A |
Up last 30 days | 1 | N/A | 1 | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | 1 |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 25.00% | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | 14.00% | N/A | N/A | N/A |
Next year | 0.50% | N/A | N/A | N/A |
Next 5 years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 years (per annum) | -1.23% | N/A | N/A | N/A |